Trial Design Webinars

  1. Rare and Orphan Diseases Patient Perceptions
    5/9/2017

    Do you face the challenge of recruiting and retaining rare disease patients for orphan drug clinical trials? Now, discover how you can boost participation, enhance outcomes and speed drug development in this competitive market.

  2. How eConsent Improves Consent Development
    11/1/2016

    Developing informed consent content requires a lot of back and forth communication between multiple stakeholders - an inefficient, slow process with a history of allowing unapproved or out-of-date consents to be accidentally deployed to sites. Electronic Informed Consent (eConsent) offers a streamlined, collaborative process that promotes faster content development, approval and deployment on one platform, guaranteeing that only the most current and approved consent version is used each time.

  3. The Value Of Electronic Informed Consent
    11/1/2016

    Securing informed consent from clinical trial participants involves more than a signature—you need to ensure participants truly understand what they’re signing.  Learn from industry expert, Sandra “SAM” Sather, on how the electronic informed consent (eConsent) process improves the way participants are consented on a clinical trial.

  4. Reducing Regulatory Risk In Clinical Trials With eConsent
    11/1/2016

    You may already know too well the challenges of a paper-based Informed Consent process, but did you know that Informed Consent is one of the most cited deficiencies by regulatory authorities? Paper-based informed consent increases your risk for delayed approvals, fines, litigation and even trial failure.

  5. 3 Major Regulatory Risks You Can Reduce With Electronic Informed Consent
    11/1/2016

    You may already know too well the challenges of a paper-based Informed Consent process, but did you know that Informed Consent is one of the most cited deficiencies by regulatory authorities? Paper-based informed consent increases your risk for delayed approvals, fines, litigation and even trial failure.

  6. Recruiting And Retaining Patients With eConsent
    11/1/2016

    The informed consent process intends to ensure trial participants understand the risks and benefits of joining your trial, but a poor experience leads to low recruitment rates and costly drop-outs. Electronic Informed Consent (eConsent) improves recruitment and retention of participants by developing better comprehension of consent materials and improving engagement for the full duration of your study. In this short video, industry expert Sandra "Sam" Sather, reviews the ways that eConsent supports and adds value to the recruitment process.

  7. Marken - IQPC 2011
    10/17/2011
    Marken’s Wes Wheeler speaks of the industry’s movement toward biologicals...with a growth rate projection of 50%. Marken is working to address that trend.